CARDURION PHARMA Trademark

Trademark Overview

On Monday, August 1, 2016, a trademark application was filed for CARDURION PHARMA with the United States Patent and Trademark Office. The USPTO has given the CARDURION PHARMA trademark a serial number of 87122661. The federal status of this trademark filing is REGISTERED as of Tuesday, July 21, 2020. This trademark is owned by Cardurion Pharmaceuticals, Inc.. The CARDURION PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
cardurion pharma

General Information

Serial Number87122661
Word MarkCARDURION PHARMA
Filing DateMonday, August 1, 2016
Status700 - REGISTERED
Status DateTuesday, July 21, 2020
Registration Number6108164
Registration DateTuesday, July 21, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesResearch and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 4, 2016
Primary Code042
First Use Anywhere DateTuesday, August 1, 2017
First Use In Commerce DateWednesday, August 1, 2018

Trademark Owner History

Party NameCardurion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameCardurion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameCardurion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 21, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 16, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 15, 2020EXAMINER'S AMENDMENT ENTERED
Monday, June 15, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 15, 2020EXAMINERS AMENDMENT E-MAILED
Monday, June 15, 2020SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, May 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 11, 2020ASSIGNED TO LIE
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 3, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 3, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 3, 2020SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, February 19, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 11, 2020USE AMENDMENT FILED
Tuesday, February 11, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2019EXTENSION 5 GRANTED
Monday, August 5, 2019EXTENSION 5 FILED
Wednesday, August 7, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 5, 2019TEAS EXTENSION RECEIVED
Friday, January 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 9, 2019EXTENSION 4 GRANTED
Wednesday, January 9, 2019EXTENSION 4 FILED
Wednesday, January 9, 2019TEAS EXTENSION RECEIVED
Wednesday, August 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2018EXTENSION 3 GRANTED
Monday, July 30, 2018EXTENSION 3 FILED
Monday, July 30, 2018TEAS EXTENSION RECEIVED
Wednesday, November 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 20, 2017EXTENSION 2 GRANTED
Monday, November 20, 2017EXTENSION 2 FILED
Monday, November 20, 2017TEAS EXTENSION RECEIVED
Wednesday, August 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2017EXTENSION 1 GRANTED
Monday, August 7, 2017EXTENSION 1 FILED
Monday, August 7, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 11, 2016ASSIGNED TO EXAMINER
Thursday, August 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma cardurion field others cardiovascular medicine trials conducting development pharmaceutical research clinical